250 related articles for article (PubMed ID: 32301482)
21. Low-frequency electro-acupuncture and physical exercise improve metabolic disturbances and modulate gene expression in adipose tissue in rats with dihydrotestosterone-induced polycystic ovary syndrome.
Mannerås L; Jonsdottir IH; Holmäng A; Lönn M; Stener-Victorin E
Endocrinology; 2008 Jul; 149(7):3559-68. PubMed ID: 18388196
[TBL] [Abstract][Full Text] [Related]
22. Reproductive and metabolic phenotype of a mouse model of PCOS.
van Houten EL; Kramer P; McLuskey A; Karels B; Themmen AP; Visser JA
Endocrinology; 2012 Jun; 153(6):2861-9. PubMed ID: 22334715
[TBL] [Abstract][Full Text] [Related]
23. Acupuncture and exercise restore adipose tissue expression of sympathetic markers and improve ovarian morphology in rats with dihydrotestosterone-induced PCOS.
Mannerås L; Cajander S; Lönn M; Stener-Victorin E
Am J Physiol Regul Integr Comp Physiol; 2009 Apr; 296(4):R1124-31. PubMed ID: 19158405
[TBL] [Abstract][Full Text] [Related]
24. Androgen Reduces Mitochondrial Respiration in Mouse Brown Adipocytes: A Model for Disordered Energy Balance in Polycystic Ovary Syndrome.
Lerner A; Kewada D; Ahmed A; Hardy K; Christian M; Franks S
Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33383677
[TBL] [Abstract][Full Text] [Related]
25. Adipocyte dysfunction in a mouse model of polycystic ovary syndrome (PCOS): evidence of adipocyte hypertrophy and tissue-specific inflammation.
Marino JS; Iler J; Dowling AR; Chua S; Bruning JC; Coppari R; Hill JW
PLoS One; 2012; 7(10):e48643. PubMed ID: 23119079
[TBL] [Abstract][Full Text] [Related]
26. Differential Strain-dependent Ovarian and Metabolic Responses in a Mouse Model of PCOS.
Binder AK; Peecher DL; Qvigstad AJ; Gutierrez SD; Magaña J; Banks DB; Korach KS
Endocrinology; 2023 Feb; 164(4):. PubMed ID: 36718579
[TBL] [Abstract][Full Text] [Related]
27. New Perspectives on the Pathogenesis of PCOS: Neuroendocrine Origins.
Walters KA; Gilchrist RB; Ledger WL; Teede HJ; Handelsman DJ; Campbell RE
Trends Endocrinol Metab; 2018 Dec; 29(12):841-852. PubMed ID: 30195991
[TBL] [Abstract][Full Text] [Related]
28. Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy.
Abbott DH; Dumesic DA; Levine JE
Expert Rev Endocrinol Metab; 2019 Mar; 14(2):131-143. PubMed ID: 30767580
[TBL] [Abstract][Full Text] [Related]
29. Antiandrogen Treatment Ameliorates Reproductive and Metabolic Phenotypes in the Letrozole-Induced Mouse Model of PCOS.
Ryan GE; Malik S; Mellon PL
Endocrinology; 2018 Apr; 159(4):1734-1747. PubMed ID: 29471436
[TBL] [Abstract][Full Text] [Related]
30. Androgen-induced upregulation of CFTR in pancreatic β-cell contributes to hyperinsulinemia in PCOS model.
Sun M; Wu Y; Yuan C; Lyu J; Zhao X; Ruan YC; Guo J; Chen H; Huang WQ
Endocrine; 2024 Jan; 83(1):242-250. PubMed ID: 37922092
[TBL] [Abstract][Full Text] [Related]
31. A Novel Letrozole Model Recapitulates Both the Reproductive and Metabolic Phenotypes of Polycystic Ovary Syndrome in Female Mice.
Kauffman AS; Thackray VG; Ryan GE; Tolson KP; Glidewell-Kenney CA; Semaan SJ; Poling MC; Iwata N; Breen KM; Duleba AJ; Stener-Victorin E; Shimasaki S; Webster NJ; Mellon PL
Biol Reprod; 2015 Sep; 93(3):69. PubMed ID: 26203175
[TBL] [Abstract][Full Text] [Related]
32. Comparison of Reproductive Function Between Normal and Hyperandrogenemia Conditions in Female Mice With Deletion of Hepatic Androgen Receptor.
Feng M; Divall S; Jones D; Ubba V; Fu X; Yang L; Wang H; Yang X; Wu S
Front Endocrinol (Lausanne); 2022; 13():868572. PubMed ID: 35757434
[TBL] [Abstract][Full Text] [Related]
33. Diet-induced obesity exacerbates metabolic and behavioral effects of polycystic ovary syndrome in a rodent model.
Ressler IB; Grayson BE; Ulrich-Lai YM; Seeley RJ
Am J Physiol Endocrinol Metab; 2015 Jun; 308(12):E1076-84. PubMed ID: 26078189
[TBL] [Abstract][Full Text] [Related]
34. Up-regulated FHL2 inhibits ovulation through interacting with androgen receptor and ERK1/2 in polycystic ovary syndrome.
Zhou R; Li S; Liu J; Wu H; Yao G; Sun Y; Chen ZJ; Li W; Du Y
EBioMedicine; 2020 Feb; 52():102635. PubMed ID: 32028069
[TBL] [Abstract][Full Text] [Related]
35. Maternal androgen excess induces cardiac hypertrophy and left ventricular dysfunction in female mice offspring.
Manti M; Fornes R; Pironti G; McCann Haworth S; Zhengbing Z; Benrick A; Carlström M; Andersson D; Stener-Victorin E
Cardiovasc Res; 2020 Mar; 116(3):619-632. PubMed ID: 31382275
[TBL] [Abstract][Full Text] [Related]
36. D-Chiro-Inositol Treatment Affects Oocyte and Embryo Quality and Improves Glucose Intolerance in Both Aged Mice and Mouse Models of Polycystic Ovarian Syndrome.
Pericuesta E; Laguna-Barraza R; Ramos-Ibeas P; Gutierrez-Arroyo JL; Navarro JA; Vera K; Sanjuan C; Baixeras E; de Fonseca FR; Gutierrez-Adan A
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32842637
[TBL] [Abstract][Full Text] [Related]
37. Regulation of androgen receptor signaling by ubiquitination during folliculogenesis and its possible dysregulation in polycystic ovarian syndrome.
Lim JJ; Lima PDA; Salehi R; Lee DR; Tsang BK
Sci Rep; 2017 Aug; 7(1):10272. PubMed ID: 28860512
[TBL] [Abstract][Full Text] [Related]
38. Understanding the Role of Androgen Action in Female Adipose Tissue.
Schiffer L; Arlt W; O'Reilly MW
Front Horm Res; 2019; 53():33-49. PubMed ID: 31499495
[TBL] [Abstract][Full Text] [Related]
39. Androgens in polycystic ovary syndrome: lessons from experimental models.
Walters KA
Curr Opin Endocrinol Diabetes Obes; 2016 Jun; 23(3):257-63. PubMed ID: 26866639
[TBL] [Abstract][Full Text] [Related]
40. Declining muscle NAD
Aflatounian A; Paris VR; Richani D; Edwards MC; Cochran BJ; Ledger WL; Gilchrist RB; Bertoldo MJ; Wu LE; Walters KA
Mol Metab; 2022 Nov; 65():101583. PubMed ID: 36096453
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
